Search clinical trials for: Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
Total 600 results
-
Northside Hospital, Inc.Merck Sharp & Dohme LLCCompletedAcute Myeloid LeukemiaUnited States
-
University of MiamiCompletedLeukemia | Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia | MyelodysplasiaUnited States
-
University of California, San DiegoNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
Boston Children's HospitalMassachusetts General Hospital; Mayo Clinic; Karolinska University Hospital; Baylor... and other collaboratorsActive, not recruitingAplastic Anemia | Dyskeratosis Congenita | Hoyeraal Hreidarsson Syndrome | Revesz SyndromeUnited States, Norway, Sweden
-
Chinese PLA General HospitalRecruiting
-
Kyverna TherapeuticsNot yet recruitingGeneralized Myasthenia Gravis | Myasthenia Gravis
-
University of LiegeBelgian Hematological SocietyRecruitingMyelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Non Hodgkin Lymphoma | Myeloproliferative Disorder | Chronic Lymphoid Leukemia | Acute Myeloid Leukemia in Remission | Myeloproliferative Syndrome | Chronic Myeloid Leukemia in Remission | Acute Lymphoid Leukemia in RemissionBelgium
-
University of California, San FranciscoNational Cancer Institute (NCI)TerminatedLymphoma | LeukemiaUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingLymphoma | Autologous Hematopoietic Stem Cell TransplantationChina
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Emory University and other collaboratorsCompletedSickle Cell Disease | Hemoglobinopathies | ThalassemiaUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedHematologic Diseases | Hemophagocytic Lymphohistiocytosis | Immunologic Diseases | Chediak-Higashi Syndrome | X-Linked Lymphoproliferative Disorders | Griscelli Syndrome | Langerhans-Cell HistiocytosisUnited States
-
National Institute of Allergy and Infectious Diseases...Johns Hopkins University; PPDActive, not recruitingLiver Transplant Recipients | Kidney Transplant RecipientsUnited States
-
Ohio State University Comprehensive Cancer CenterCelgene CorporationRecruitingCutaneous T-cell Lymphoma | Peripheral T-Cell Lymphoma | T-Prolymphocytic Leukemia | T-Large Granulocytic Leukemia | T-Lymphoblastic Leukemia/LymphomaUnited States
-
Sherif S. FaragTerminatedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | MyelodysplasiaUnited States
-
University of LouisvilleWithdrawn
-
M.D. Anderson Cancer CenterTerminatedBreast Cancer | Ovarian CancerUnited States
-
Northside Hospital, Inc.TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Washington University School of MedicineTerminatedSickle Cell DiseaseUnited States
-
University of Illinois at ChicagoCompletedMultiple Myeloma, Relapsed | Multiple Myeloma, Refractory to Standard TreatmentUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingSickle Cell Disease | Congenital Hemolytic AnemiaUnited States
-
New Approaches to Neuroblastoma Therapy ConsortiumNational Cancer Institute (NCI)Completed
-
St. Anna KinderkrebsforschungCompletedChronic Myeloid LeukemiaAustria, Czechia, Italy
-
Medical College of WisconsinNational Heart, Lung, and Blood Institute (NHLBI); Dana-Farber Cancer Institute and other collaboratorsCompletedSickle Cell DiseaseUnited States
-
Samsung Medical CenterMinistry of Health, Republic of KoreaUnknownHigh Risk Neuroblastoma
-
National Cancer Institute (NCI)CompletedColorectal Cancer | Metastatic CancerUnited States
-
Ciceri FabioCompletedMyelodysplastic Syndromes | Fungal Infection | Graft Vs Host Disease | Leukemia, Acute | Transplant-Related Hematologic MalignancyItaly
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...TerminatedLymphoproliferative Disorders | Hematologic Diseases | Multiple Myeloma | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Plasma Cell Dyscrasia | Myelodysplastic and Myeloproliferative DisordersUnited States
-
National Institute of Arthritis and Musculoskeletal...University of Pittsburgh; Genzyme, a Sanofi Company; AmgenTerminatedSystemic Sclerosis | SclerodermaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaGermany, Austria
-
St. Jude Children's Research HospitalCompletedHodgkin Lymphoma | Myelodysplastic Syndrome (MDS) | Leukemia, Acute Lymphocytic (ALL) | Juvenile Myelomonocytic Leukemia (JMML) | Leukemia, Myeloid, Acute(AML) | Leukemia, Myeloid, Chronic(CML) | Hemoglobinuria, Paroxysmal Nocturnal (PNH) | Lymphoma, Non-Hodgkin (NHL)United States
-
Samsung Medical CenterCompletedNeuroblastomaKorea, Republic of
-
Seoul National University HospitalUnknownBrain TumorsKorea, Republic of
-
National Heart, Lung, and Blood Institute (NHLBI)TerminatedLeukemia | Chronic Myeloproliferative Disorders | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
M.D. Anderson Cancer CenterWithdrawnLymphoma | Leukemia | Stem Cell Transplantation | Pediatric Disorders
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
Wen-Kai WengCompletedMultiple Myeloma | Blood CancerUnited States
-
Baylor College of MedicineTerminated
-
Nationwide Children's HospitalWithdrawnCrohn's Disease
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedChronic Myelogenous Leukemia | Acute Leukemias | Burkitt's LymphomaUnited States
-
University of ArkansasBristol-Myers Squibb; Altor BioScienceWithdrawnMultiple MyelomaUnited States
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class IIIGermany
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - World Health Organization (WHO) Class III | Lupus Nephritis - WHO Class IVUnited States
-
Thomas Jefferson UniversityRecruitingHematopoietic and Lymphoid Cell Neoplasm | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Myeloid Leukemia | Polycythemia Vera | Essential Thrombocythemia | Hodgkin Lymphoma | Myelofibrosis | Chronic Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma and other conditionsUnited States
-
Weill Medical College of Cornell UniversityTerminatedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Acute Myelogenous LeukemiaUnited States
-
Fred Hutchinson Cancer CenterRecruitingNon-Neoplastic Hematologic and Lymphocytic DisorderUnited States
-
Yale UniversityCompleted
-
M.D. Anderson Cancer CenterPfizerNot yet recruitingMultiple Myeloma | Post-transplant MRD-guided Maintenance Therapy | Pre-transplant PurgingUnited States
-
Steven E. CoutreBayerCompletedLeukemia | Chronic Lymphocytic Leukemia (CLL) | Chronic Leukemia | B-cell LeukemiaUnited States